Risk of invasive pneumococcal disease in children and adults with asthma: A systematic review

Vaccine

Volumn 31, Issue 42, 2013, Pages 4820-4826

  Boikos, Constantina ^a   Quach, Caroline ^a,b,c,d  

^a MCGILL UNIVERSITY   (Canada)

^b MONTREAL CHILDREN S HOSPITAL   (Canada)

^c INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^d RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Asthma; Invasive pneumococcal disease; Pneumococcal vaccination

Indexed keywords

PNEUMOCOCCUS VACCINE;

ADULT DISEASE; ARTICLE; ASTHMA; CHILDHOOD DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; HIGH RISK POPULATION; HUMAN; IMMUNIZATION; INFECTION RISK; OUTCOME ASSESSMENT; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

ASTHMA; INVASIVE PNEUMOCOCCAL DISEASE; PNEUMOCOCCAL VACCINATION;

ASTHMA; BACTEREMIA; CANADA; FEMALE; HUMANS; MALE; MENINGITIS, BACTERIAL; PNEUMOCOCCAL INFECTIONS; RISK FACTORS;

EID: 84884207520     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.07.079     Document Type: Article

References (19)

1. WHO Initiative for Vaccine Research (IVR). Streptococcus pneumoniae 2009.
2. CDC. Vaccines and Immunizations Pneumococcal Disease.
3. National Advisory Committee on Immunization (NACI) Pneumococcal vaccine. Canadian Immunization Guide 2012, NACI, Ottawa. 7th ed. Public Health Agency of Canada (PHAC) (Ed.).
4. Talbot T.R., Hartert T.V., Mitchel E., Halasa N.B., Arbogast P.G., Poehling K.A., et al. Asthma as a risk factor for invasive pneumococcal disease. New England Journal of Medicine 2005, 352:2082-2090.
5. Juhn Y.J., Kita H., Yawn B.P., Boyce T.G., Yoo K.H., McGree M.E., et al. Increased risk of serious pneumococcal disease in patients with asthma. Journal of Allergy and Clinical Immunology 2008, 122:719-723.
6. Flory J.H., Joffe M., Fishman N.O., Edelstein P.H., Metlay J.P. Socioeconomic risk factors for bacteraemic pneumococcal pneumonia in adults. Epidemiology & Infection 2009, 137:717-726.
7. Klemets P., Lyytikainen O., Ruutu P., Ollgren J., Kaijalainen T., Leinonen M., et al. Risk of invasive pneumococcal infections among working age adults with asthma. Thorax 2010, 65:698-702.
8. Pilishvili T., Zell E.R., Farley M.M., Schaffner W., Lynfield R., Nyquist A.C., et al. Risk factors for invasive pneumococcal disease in children in the era of conjugate vaccine use. Pediatrics 2010, 126:e9-e17.
9. Hsu K.K., Shea K.M., Stevenson A.E., Pelton S.I., Members of the Massachusetts Department of Public H Underlying conditions in children with invasive pneumococcal disease in the conjugate vaccine era. Pediatric Infectious Disease Journal 2011, 30:251-253.
10. StatsCan Asthma, by Sex, Provinces and Territories (Number of Persons) 2012, StatsCan, Canada.
11. Harris R.P., Helfand M., Woolf S.H., Lohr K.N., Mulrow C.D., Teutsch S.M., et al. Current methods of the US Preventive Services Task Force: a review of the process. American Journal of Preventive Medicine 2001, 20:21-35.
12. Watt J.P., O'Brien K.L., Benin A.L., McCoy S.I., Donaldson C.M., Reid R., et al. Risk factors for invasive pneumococcal disease among Navajo adults. American Journal of Epidemiology 2007, 166:1080-1087.
13. Hjuler T., Wohlfahrt J., Staum Kaltoft M., Koch A., Biggar R.J., Melbye M. Risks of invasive pneumococcal disease in children with underlying chronic diseases. Pediatrics 2008, 122:e26-e32.
14. Tunkel A.R., Van de Beek D., Scheld W.M. Acute meningitis. Principles and Practices of Infectious Diseases 2010, 1189-1229. Churchill Livingstone Elsevier, Philpadelphia, PA. 7th ed. G.L. Mandell, J.E. Bennett, R. Dolin (Eds.).
15. Kuss O., Stang A. The p-value - a well-understood and properly used statistical concept. Contact Dermatitis 2012, 66:1-3.
16. Ranstam J. Why the P-value culture is bad and confidence intervals a better alternative. Osteoarthritis and Cartilage 2012, 20:805-808.
17. Ochoa-Gondar O., Vila-Corcoles A., Ansa X., Rodriguez-Blanco T., Salsench E., de Diego C., et al. Effectiveness of pneumococcal vaccination in older adults with chronic respiratory diseases: results of the EVAN-65 study. Vaccine 2008, 26:1955-1962.
18. Canada PHAo Part 4: Active Vaccines 2012, Canadian Immunization Guide, Canada.
19. Jung J.A., Kita H., Dhillon R., Jacobson R.M., Nahm M.H., Park M., et al. Influence of asthma status on serotype-specific pneumococcal antibody levels. Postgraduate Medicine 2010, 122:116-124.